Plain-English translation of NCT07566390 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage safety study of a new medication called , designed to help people with excess body weight. Researchers will give participants a single injection of the medication (or a placebo) and carefully monitor how their bodies respond. The goal is to understand whether this treatment is safe and how the body processes it.
There is a need for new treatment options for people struggling with overweight and obesity. This medication has shown promise in laboratory and animal studies, but it has never been tested in humans before. This trial is the critical first step to determine if it is safe enough to study further.
You likely qualify if…
You likely don't qualify if…
You will attend screening visits where doctors will check your health with blood work, heart tests, and a physical exam. If you qualify, you will receive one injection under the skin of either the new medication or a placebo—you won't know which one. You may be monitored in the clinic for a period after the injection, and you will have follow-up appointments where the research team checks how you are feeling and takes blood samples to track how your body processes the medication.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States